401 related articles for article (PubMed ID: 37071471)
1. Obesity-induced inflammation exacerbates clonal hematopoiesis.
Pasupuleti SK; Ramdas B; Burns SS; Palam LR; Kanumuri R; Kumar R; Pandhiri TR; Dave UP; Yellapu NK; Zhou X; Zhang C; Sandusky GE; Yu Z; Honigberg MC; Bick AG; Griffin GK; Niroula A; Ebert BL; Paczesny S; Natarajan P; Kapur R
J Clin Invest; 2023 Jun; 133(11):. PubMed ID: 37071471
[TBL] [Abstract][Full Text] [Related]
2. Clonal Hematopoiesis of Indeterminate Potential in Patients with Solid Tumor Malignancies.
Marshall CH; Gondek LP; Luo J; Antonarakis ES
Cancer Res; 2022 Nov; 82(22):4107-4113. PubMed ID: 36040522
[TBL] [Abstract][Full Text] [Related]
3. Clonal hematopoiesis: Molecular and clinical implications.
Kusne Y; Xie Z; Patnaik MM
Leuk Res; 2022 Feb; 113():106787. PubMed ID: 35091334
[TBL] [Abstract][Full Text] [Related]
4. Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation.
Goldman EA; Spellman PT; Agarwal A
Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 36889927
[TBL] [Abstract][Full Text] [Related]
5. Clonal hematopoiesis and associated diseases: A review of recent findings.
Asada S; Kitamura T
Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
[TBL] [Abstract][Full Text] [Related]
6. Aging drives Tet2+/- clonal hematopoiesis via IL-1 signaling.
Caiado F; Kovtonyuk LV; Gonullu NG; Fullin J; Boettcher S; Manz MG
Blood; 2023 Feb; 141(8):886-903. PubMed ID: 36379023
[TBL] [Abstract][Full Text] [Related]
7. [Importance of clonal hematopoiesis for hematologic neoplasms].
Götze KS; Lengerke C
Inn Med (Heidelb); 2022 Nov; 63(11):1107-1114. PubMed ID: 36125513
[TBL] [Abstract][Full Text] [Related]
8. Review of clonal hematopoiesis, subtypes and its role in neoplasia and different morbidities.
Younes IE; Syler L; Hamed A
Leuk Res; 2023 Jul; 130():107307. PubMed ID: 37186988
[TBL] [Abstract][Full Text] [Related]
9. Clonal hematopoiesis and inflammation: A review of mechanisms and clinical implications.
Nathan DI; Dougherty M; Bhatta M; Mascarenhas J; Marcellino BK
Crit Rev Oncol Hematol; 2023 Dec; 192():104187. PubMed ID: 37879493
[TBL] [Abstract][Full Text] [Related]
10. Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease.
Marnell CS; Bick A; Natarajan P
J Mol Cell Cardiol; 2021 Dec; 161():98-105. PubMed ID: 34298011
[TBL] [Abstract][Full Text] [Related]
11. Clinical consequences of clonal hematopoiesis of indeterminate potential.
Steensma DP
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):264-269. PubMed ID: 30504320
[TBL] [Abstract][Full Text] [Related]
12. Exploring the Associations Between Clonal Hematopoiesis of Indeterminate Potential, Myeloid Malignancy, and Atherosclerosis.
Menendez-Gonzalez JB; Rodrigues NP
Methods Mol Biol; 2022; 2419():73-88. PubMed ID: 35237959
[TBL] [Abstract][Full Text] [Related]
13. Genetic modification of inflammation- and clonal hematopoiesis-associated cardiovascular risk.
Yu Z; Fidler TP; Ruan Y; Vlasschaert C; Nakao T; Uddin MM; Mack T; Niroula A; Heimlich JB; Zekavat SM; Gibson CJ; Griffin GK; Wang Y; Peloso GM; Heard-Costa N; Levy D; Vasan RS; Aguet F; Ardlie KG; Taylor KD; Rich SS; Rotter JI; Libby P; Jaiswal S; Ebert BL; Bick AG; Tall AR; Natarajan P
J Clin Invest; 2023 Sep; 133(18):. PubMed ID: 37498674
[TBL] [Abstract][Full Text] [Related]
14. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.
Jaiswal S; Natarajan P; Silver AJ; Gibson CJ; Bick AG; Shvartz E; McConkey M; Gupta N; Gabriel S; Ardissino D; Baber U; Mehran R; Fuster V; Danesh J; Frossard P; Saleheen D; Melander O; Sukhova GK; Neuberg D; Libby P; Kathiresan S; Ebert BL
N Engl J Med; 2017 Jul; 377(2):111-121. PubMed ID: 28636844
[TBL] [Abstract][Full Text] [Related]
15. Distinction of lymphoid and myeloid clonal hematopoiesis.
Niroula A; Sekar A; Murakami MA; Trinder M; Agrawal M; Wong WJ; Bick AG; Uddin MM; Gibson CJ; Griffin GK; Honigberg MC; Zekavat SM; Paruchuri K; Natarajan P; Ebert BL
Nat Med; 2021 Nov; 27(11):1921-1927. PubMed ID: 34663986
[TBL] [Abstract][Full Text] [Related]
16. Clonal hematopoiesis of indeterminate potential and cardiovascular disease.
Saadatagah S; Ballantyne CM
Transl Res; 2023 May; 255():152-158. PubMed ID: 36067904
[TBL] [Abstract][Full Text] [Related]
17. TET2-Loss-of-Function-Driven Clonal Hematopoiesis Exacerbates Experimental Insulin Resistance in Aging and Obesity.
Fuster JJ; Zuriaga MA; Zorita V; MacLauchlan S; Polackal MN; Viana-Huete V; Ferrer-Pérez A; Matesanz N; Herrero-Cervera A; Sano S; Cooper MA; González-Navarro H; Walsh K
Cell Rep; 2020 Oct; 33(4):108326. PubMed ID: 33113366
[TBL] [Abstract][Full Text] [Related]
18. CHIP Happens: Clonal Hematopoiesis of Indeterminate Potential and Its Relationship to Solid Tumors.
Reed SC; Croessmann S; Park BH
Clin Cancer Res; 2023 Apr; 29(8):1403-1411. PubMed ID: 36454121
[TBL] [Abstract][Full Text] [Related]
19. Clinical manifestations of clonal hematopoiesis: What has SF3B1-mutant MDS taught us?
Todisco G; Moura PL; Hellström-Lindberg E
Semin Hematol; 2022 Jul; 59(3):150-155. PubMed ID: 36115692
[TBL] [Abstract][Full Text] [Related]
20. Clinical consequences of clonal hematopoiesis of indeterminate potential.
Steensma DP
Blood Adv; 2018 Nov; 2(22):3404-3410. PubMed ID: 30482770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
